PMNs are central to the immunopathogenesis of sepsis and represent promising biomarkers and therapeutic targets. Further studies on neutrophil heterogeneity, metabolic adaptation, and immune interactions may support the development of more precise diagnostic and immunomodulatory strategies.
Liu et al. (Wed,) studied this question.